Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Nippon Kayaku (4272 JP)
Watchlist
21
Analysis
Materials
•
Japan
NIPPON KAYAKU CO., LTD. is a diversified chemical producer. The Company manufactures pharmaceuticals, dyestuffs, agrochemicals, explosives and synthetic resins. The Company also produces airbag inflators.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
25 Sep 2018 19:48
Japan Pharma: Core Coverage Investment Thesis and Valuations (III/III)
Takeda Pharmaceutical (4502 JP), Astellas Pharma (4503 JP), Daiichi Sankyo (4568 JP), Eisai Co Ltd (4523 JP), Otsuka Holdings (4578 JP), Chugai...
Dion Stéfan Büchner M.D., FCAP
513 Views
Share
bullish
•
Thematic (Sector/Industry)
•
25 Sep 2018 19:43
Japan Pharma: Core Coverage Investment Thesis and Valuations (II/III)
Takeda Pharmaceutical (4502 JP), Astellas Pharma (4503 JP), Daiichi Sankyo (4568 JP), Eisai Co Ltd (4523 JP), Otsuka Holdings (4578 JP), Chugai...
Dion Stéfan Büchner M.D., FCAP
425 Views
Share
bullish
•
Thematic (Sector/Industry)
•
25 Sep 2018 19:38
Japan Pharma: Core Coverage Investment Thesis and Valuations (I/III)
Takeda Pharmaceutical (4502 JP), Astellas Pharma (4503 JP), Daiichi Sankyo (4568 JP), Eisai Co Ltd (4523 JP), Otsuka Holdings (4578 JP), Chugai...
Dion Stéfan Büchner M.D., FCAP
449 Views
Share
bullish
•
Asahi Kasei
•
30 Aug 2016 14:23
USD/JPY Macro Low and Fresh Position Webcast
Chartonics flash Tuesday 30 August 2016USD/JPY macro low and position update webcastWe have made a USD bull case from JPY 100 or 95 if we broke...
Thomas Schroeder
4.2k Views
Share
bullish
•
NOF
•
26 Oct 2025 10:49
Shorting NOF (4403) Just Now Is Probably a Very Bad Idea
Japan's defense budget increase may boost NOF's ammunition business, but production limits and slow capacity expansion could hinder profit growth....
Michael Allen
Follow
689 Views
Share
Previous
1
2
3
4
5
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x